Large economic and political forces are re-shaping the entire healthcare industry. This wave of change will affect and constrain the opportunities for the marketing of biopharmaceuticals, medical devices and diagnostics for years to come. Despite these changes, two requisites will remain important – in all likelihood becoming even more important – to marketers:
- Understanding how providers and patients make healthcare decisions
- Knowing how to influence those decisions
How can we possibly account for everything that might impact the adoption of a new pharmaceutical product without making the assessment overwhelming for physicians? This white paper outlines the details of Healogix best practices starting with an important distinction from Behavioral Economics.
READ THIS WHITEPAPER